PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of the expansion of its new Biotech Center of Excellence in Philadelphia, Pennsylvania, a major investment that will represent the new U.S. biologics flagship site for customers. In addition, PCI is also announcing significant new investments to expand its global packaging capabilities for biologic drug products at its operations in Ireland, complementing existing capabilities in UK and Germany. These investments will provide customers with global packaging solutions for their biologics and injectable drug products to meet growing market demands.
“Worldwide forecasts for biologics show strong growth over the next several years, and PCI is staying on top of this trend and investing in the latest technology to enhance capacity and accommodate the novel drug delivery formats of biologic products. We have already secured projects from numerous global biopharmaceutical customers that will benefit from the new expansion, which is a reflection of the market demand,” said Salim Haffar, chief executive officer, PCI Pharma Services. “PCI has a rich heritage in biologics going back more than 20 years, but we now have the opportunity to apply this expertise on a larger scale. We are looking forward to leveraging our breadth of experience with the latest technology to help our customers bring life-changing therapies to patients.”
The recent investments include partnerships with leading suppliers such as Dividella, groninger, Marchesini Group and Syntegon (formerly Bosch Packaging Technology) to provide state-of-the-art equipment for pre-filled syringe, auto-injector and vial packaging and the latest serialization technology. The expansions also include increasing high-speed automatic syringe assembly and labeling, vial labeling and cartoning, and auto-injector assembly – allowing for greater flexibility in serving customers across their supply-chain requirements. In addition to building out existing cold storage capabilities and leading-edge manufacturing suites, PCI will continue to offer innovative design teams to help address the packaging challenges often presented by biologic products.
“With these expansions, our Biotech Centers of Excellence are prepared to support the scale required to meet customers’ needs all over the world,” said Brad Payne, chief operating officer, PCI Pharma Services. “PCI has the flexibility to handle the dynamic volumes of biopharmaceutical therapies, whether large or small, catering to the needs of our global customer base. This flexibility extends to the varied capacities needed for launches, global ramp-up and ongoing supply. With these investments in high-speed automation, PCI will dramatically improve productivity as well as supply continuity and quality.”
Find out more about biologics packaging by PCI Pharma Services here.
About PCI Pharma Services
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pci.com or follow us on Twitter at @PCI_Social.
Bailey Watroba, WE Communications
firstname.lastname@example.org / +1-617-234-4110
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Global Expands in the Caribbean2.7.2020 15:30:00 CEST | Press release
Andersen Global announced it entered into a Collaboration Agreement with San Juan, Puerto Rico-based, full-service tax firm BDO Tax LLC, marking the organization’s debut in the region. Founded in 2000, BDO Tax LLC is led by Managing Partner Gaby Hernandez and supported by more than 140 professionals. It provides an array of tax and business advisory services to more than 3,000 clients, including transfer pricing, private client services, transaction advisory, government contracting, accounting services and tax compliance with a specific focus on international tax and inbound tax advisory. “As a former Arthur Andersen professional, I appreciate the importance and impact of working with like-minded individuals who share similar values and commitment to their clients,” Gaby said. “Collaborating with Andersen Global enhances our ability to deliver seamless coverage globally and provide a more comprehensive range of services.” “Gaby has built one of the strongest practices in the region and
Skilling lanserar MT42.7.2020 15:10:00 CEST | Pressmeddelande
Forex- och CFD-handelsplattformen Skilling nådde ytterligare en viktig milstolpe i år med integrationen och lanseringen av handelsplattformen MetaTrader 4 (MT4). Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20200702005313/sv/ Skilling lanserar MT4 (Photo: Business Wire) Skilling grundades 2016 och introducerade sin egen handelsplattform 2018. I januari 2020 tillkännagav de lanseringen av branschens första sömlösa integration med Spotware cTrader. Med deras förvärv av en licens från FSA Seychellerna tidigare i år kan Skilling nu erbjuda MT4 till sina nuvarande och nya kunder på global nivå. ”Vi har arbetat outtröttligt för att lansera den berömda MetaTrader 4, även känd som MT4, den elektroniska handelsplattformen som allmänt används av investerare runt om i världen. Idag är vi stolta över att äntligen kunna erbjuda våra kunder en mycket anpassningsbar plattform med många avancerade verktyg och funktioner, till exem
Zynga Closes Transformational Acquisition of Istanbul-based Peak; Expands Forever Franchise Portfolio with Toon Blast and Toy Blast2.7.2020 15:05:00 CEST | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, and Peak, Istanbul-based creator of Toon Blast and Toy Blast, announced today that the companies have closed the transaction under which Zynga acquired all of the issued and outstanding common shares of Peak for a total purchase price of approximately $1.85 billion comprised approximately of equal contributions of cash and Zynga common stock. Peak brings to Zynga a renowned, talented team and two forever franchises, Toon Blast and Toy Blast, that have consistently ranked within the top 10 and top 20 U.S. iPhone grossing games for the past two years, respectively. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200702005008/en/ Zynga Closes Transformational Acquisition of Istanbul-based Peak; Expands Forever Franchise Portfolio with Toon Blast and Toy Blast (Graphic: Business Wire) Peak will continue to be led by founder and Chief Executive Officer Sidar
Smiths Detection launches iCMORE algorithms for lithium batteries and dangerous goods for HI-SCAN 10080 XCT2.7.2020 11:00:00 CEST | Press release
Smiths Detection, a leading detection and security company, has launched iCMORE detection algorithms for lithium batteries and dangerous goods for use by its HI-SCAN 10080 XCT scanner, becoming its first explosive-detection system (EDS) to offer these options. The algorithms enhance the scanner’s detection capabilities by helping identify lithium batteries, flammable liquids and solids, and compressed and liquefied gasses, which can pose a risk should they ignite or explode. With iCMORE, Smiths Detection can now reliably and accurately detect potentially dangerous lithium batteries, alongside other dangerous goods, across both its conventional X-ray and its EDS technologies. The iCMORE lithium batteries and dangerous goods algorithms are complementary adaptions to existing screening technology. Although the screening of dangerous goods is not yet mandatory in hold-baggage and air-cargo screening, the increased level of safety for passengers, staff and assets is a key driver for the imp
EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome2.7.2020 10:00:00 CEST | Press release
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). Siltuximab is a monoclonal antibody that directly neutralizes interleukin (IL)-6, an inflammatory cytokine detected at elevated levels in multiple inflammatory conditions, including COVID-19. It specifically binds to IL-6, thereby inactivating IL-6 induced signalling. Lee Morley, Chief Executive Officer, EUSA Pharma, said:“Since the start of the pandemic, a growing body of evidence has been published highlighting that COVID-19 associated ARDS may exhibit features of systemic hyperinflammation, resulting from excessive cytokine production – the so-called ‘cytokine storm’ – wi
Deenova Multiplies its Pharmacy Automation Market Presence into 7 European Countries2.7.2020 09:34:00 CEST | Press release
Deenova reported today its 2020 step-by-step but relentless continued geographic expansion into Austria, Belgium, France, Germany, Portugal, Spain, and Switzerland, with three new and seasoned business development staff totaling 66 years of healthcare industry experience. Christophe Jaffuel, Deenova’s International Business Development Director, stated: “I am extremely pleased to add Carlos Duran (formerly from Becton Dickinson-Carefusion-Rowa), Thierry Geraud (previously from Becton Dickinson-Carefusion-Pyxis) and Hilmi Sunay (recently from Omnicell-Health Robotics and Arxium-IHS Riva) to an already strong Deenova sales team. These 3 extremely talented and experienced individuals joined Deenova because of its unique technology and business approach to R.O.I., and total service solutions proven in the health care industry. I was equally impressed with Deenova’s demonstrated results when I joined the company 6 months ago, witnessing first-hand how Deenova simultaneously improves patient
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom